If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying. Last week there they were, as congressional blowhards attacked the greedy pharmaceutical industry for high drug prices. Are some too high? Sure, but failure is very expensive in the pharmaceutical arena. Politicians don’t care, and never turn down a good venue to harangue a company spokesperson for populous gains.
